Status:
COMPLETED
Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military
Lead Sponsor:
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Conditions:
Yellow Fever Vaccine
Eligibility:
MALE
18+ years
Brief Summary
Yellow fever is an acute viral disease transmitted by mosquitoes in South America, Central America and Africa. It is more prevalente in males gender and the age above 15 years due to the greater expos...
Detailed Description
This is an observational study in young adult males who received the first dose of the yellow fever vaccine in 2009 when they participated in the "Dose-response study of the yellow fever vaccine 17DD ...
Eligibility Criteria
Inclusion
- Participated in the "Dose-response study of the yellow fever vaccine 17DD produced by Bio-Manguinhos / Fiocruz" in 2009.
- Not been revaccinated during the "Dose-response study of the yellow fever vaccine 17DD produced by Bio-Manguinhos / Fiocruz" of 2009.
- Not having received another dose of the 17DD yellow fever vaccine after participating in the 2009 "Bio-Manguinhos / Fiocruz" 17DD yellow fever vaccine dose-response study.
- Provide name, address, telephone and other information so that you can contact if necessary.
- Ability to understand and sign the TCLE.
Exclusion
- Impossibility or refusal to collect blood
Key Trial Info
Start Date :
March 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 4 2017
Estimated Enrollment :
374 Patients enrolled
Trial Details
Trial ID
NCT03338231
Start Date
March 27 2017
End Date
September 4 2017
Last Update
November 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bio-Manguinhos/Fiocruz
Rio de Janeiro, Brazil, 21040-360